Teladoc Health (TDOC) is expected to see a 0.8% Y/Y drop in its fourth-quarter revenue, scheduled to be released on February 25 after market close.
The consensus EPS estimate is -$0.22, while revenue is expected to be around $635.33M.
The company had guided 2025 consolidated revenue of $2.510 billion to $2.539 billion and adjusted EBITDA of $270 million to $287 million in the previous quarter. Free cash flow is expected in the range of $170 million to $185 million, it added.
The management projected the Integrated Care segment revenue to rise 2.4% to 3.5%, while it sees BetterHelp revenue narrowing, expecting a decline in the range of 8% to 9.2%.
The company anticipated $12 million to $14 million in 2025 insurance revenue for BetterHelp and updated segment adjusted EBITDA margin guidance to 3.8% to 4.6%.
Teladoc cited persistent headwinds in the U.S. BetterHelp cash-pay segment, coupled with macroeconomic uncertainty and intensifying competition, particularly from insurance-backed providers. It also flagged potential risks due to tariffs, expecting a $3 million hit to adjusted EBITDA.
Seeking Alpha analyst Stephen Ayers expects TDOC’s 2026 revenue guidance to be at least flat, with free cash flow margin meaningfully above ~5%.
“For its BetterHelp segment, users, and revenues need to stabilize, and segment profitability needs to increase. Its Integrated Care unit needs to see monetization improvement. And investors need to be assured that there is a clear path for capital structure and cash durability into 2027,” Ayers said.